These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 19941080

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
    Makino T, Yamasaki M, Miyata H, Yoshioka S, Takiguchi S, Fujiwara Y, Nakajima K, Nishida T, Mori M, Doki Y.
    Ann Surg Oncol; 2010 Mar; 17(3):804-11. PubMed ID: 19885698
    [Abstract] [Full Text] [Related]

  • 3. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma.
    Perrone F, Bossi P, Cortelazzi B, Locati L, Quattrone P, Pierotti MA, Pilotti S, Licitra L.
    J Clin Oncol; 2010 Feb 10; 28(5):761-6. PubMed ID: 20048189
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H, Natsugoe S, Matsumoto M, Yokomakura N, Uchikado Y, Takatori H, Ishigami S, Takao S, Aikou T.
    J Surg Oncol; 2005 Jul 01; 91(1):84-9. PubMed ID: 15999354
    [Abstract] [Full Text] [Related]

  • 6. [Multivariate analysis of the prognostic and predictive factors of response to concomitant radiochemotherapy in epidermoid cancers of the esophagus. Value of immunodetection of protein p53].
    Seitz JF, Perrier H, Monges G, Giovannini M, Gouvernet J.
    Gastroenterol Clin Biol; 1995 May 01; 19(5):465-74. PubMed ID: 7589997
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
    Miyata H, Yoshioka A, Yamasaki M, Nushijima Y, Takiguchi S, Fujiwara Y, Nishida T, Mano M, Mori M, Doki Y.
    Cancer; 2009 Jul 15; 115(14):3324-34. PubMed ID: 19452547
    [Abstract] [Full Text] [Related]

  • 10. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P, Temam S, Charlotte F, Lacau-St-Guily J.
    Br J Cancer; 2002 Dec 02; 87(12):1390-5. PubMed ID: 12454767
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [p53 mutations and chemoresistance in oromaxillofacial squamous-cell carcinomas. The results of a molecular genetics study of p53 in metastatic oromaxillofacial tumors and an evaluation of the response to neoadjuvant chemotherapeutic treatment].
    Cutilli T, Papola F, Di Emidio P, Leocata P, Corbacelli A.
    Minerva Stomatol; 1998 Dec 02; 47(1-2):1-9. PubMed ID: 9578641
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma.
    Ribeiro U, Finkelstein SD, Safatle-Ribeiro AV, Landreneau RJ, Clarke MR, Bakker A, Swalsky PA, Gooding WE, Posner MC.
    Cancer; 1998 Jul 01; 83(1):7-18. PubMed ID: 9655287
    [Abstract] [Full Text] [Related]

  • 15. Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma.
    Licitra L, Suardi S, Bossi P, Locati LD, Mariani L, Quattrone P, Lo Vullo S, Oggionni M, Olmi P, Cantù G, Pierotti MA, Pilotti S.
    J Clin Oncol; 2004 Dec 15; 22(24):4901-6. PubMed ID: 15611505
    [Abstract] [Full Text] [Related]

  • 16. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG, Hsu HK, Chang HC, Chou YP, Chiang KH, Cheng JT.
    Ann Thorac Surg; 2005 Sep 15; 80(3):1007-16. PubMed ID: 16122475
    [Abstract] [Full Text] [Related]

  • 17. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
    Iizuka N, Hirose K, Noma T, Hazama S, Tangoku A, Hayashi H, Abe T, Yamamoto K, Oka M.
    Br J Cancer; 1999 Oct 15; 81(3):469-75. PubMed ID: 10507772
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M, Hitt R, Medina PP, Gamarra S, Manso L, Cortes-Funes H, Sanchez-Cespedes M.
    J Clin Oncol; 2006 Sep 10; 24(26):4333-9. PubMed ID: 16896002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.